Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for smarcb1 protein human
Most Correlated Studies
- Atypical teratoid/rhabdoid tumors (AT/RT) and AT/RT-like tumors differing in INI1 staining
- Rhabdomyosarcoma A-204 cells treated with dasatinib or pazopanib or sunitinib
- Kidney rhabdoid tumor G401 cells with CRISPR-cas9 mediated BRD9 knockout
- Kidney cancer G-401 cells with BRD9 gene knockout
- Gene expression in rhabdoid tumors
Most Relevant Literature
- SMARCB1/INI1-deficient undifferentiated carcinoma of the ileum with features of rhabdoid tumor: A ca…
- Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.
- Treatment for SMARCB1 (INI-1) deficient sinonasal tumor: a single-institution study.
- SMARCB1-deficient renal medullary carcinoma with revealed by a supra-clavicular metastatic lymph nod…
- Clinical management of desmoplastic myxoid tumor, SMARCB1-mutant.
Most Relevant Clinical Trials
- A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-P…
- Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficien…
- FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors
- Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidn…
- Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma
